Skip to main content
Download PDF
Download ePub

Correction: MicroRNA-30a-5pme: a novel diagnostic and prognostic biomarker for clear cell renal cell carcinoma in tissue and urine samples

Journal of Experimental & Clinical Cancer Research volume 41, Article number: 247 (2022) Cite this article

The Original Article was published on 01 June 2020

Correction: J Exp Clin Cancer Res 39, 98 (2020)

https://doi.org/10.1186/s13046-020-01600-3

Following publication of the original article [1], an error was identified in Supplementary Figure 1 where incorrectly labelled graphs were found; specifically:

  • Supplementary Figure 1: the y axis is currently labelled as miR-30c-5p expression (normalized to RNU48) whereas it should be labelled as miR-30a-5p expression (normalized to RNU48); correct supplementary file is now used

The correction does not have any effect on the results or conclusions of the paper. The original article has been corrected.

Reference

  1. Outeiro-Pinho G, Barros-Silva D, Aznar E, et al. MicroRNA-30a-5pme: a novel diagnostic and prognostic biomarker for clear cell renal cell carcinoma in tissue and urine samples. J Exp Clin Cancer Res. 2020;39:98. https://doi.org/10.1186/s13046-020-01600-3.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Author notes

  1. Gonçalo Outeiro-Pinho and Daniela Barros-Silva are joint first authors.

Authors and Affiliations

  1. Cancer Biology and Epigenetics Group, IPO Porto Research Center (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto), Rua Dr. António Bernardino de Almeida, 4200-072, Porto, Portugal

    Gonçalo Outeiro-Pinho, Daniela Barros-Silva, Elena Aznar, Ana-Isabel Sousa, Márcia Vieira-Coimbra, Rui Henrique & Carmen Jerónimo

  2. Master in Molecular Medicine and Oncology, Faculty of Medicine-University of Porto (FMUP), Porto, Portugal

    Gonçalo Outeiro-Pinho

  3. Instituto Interuniversitario de Investigación de Reconocimiento Molecular y Desarrollo Tecnológico (IDM), Universitat de València, CIBER de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Camino de Vera s/n, 46022, Valencia, Spain

    Elena Aznar

  4. Department of Urology, Portuguese Oncology Institute of Porto (IPO Porto), Rua Dr. António, Bernardino de Almeida, 4200-072, Porto, Portugal

    Jorge Oliveira

  5. Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Campus de Gualtar, Braga, Portugal

    Céline S. Gonçalves & Bruno M. Costa

  6. ICVS/3B’s - PT Government Associate Laboratory, Braga/Guimarães, University of Minho, Campus de Gualtar, Braga, Portugal

    Céline S. Gonçalves & Bruno M. Costa

  7. Department of Urology and Pediatric Urology, Saarland University, Homburg, Saar, Germany

    Kerstin Junker

  8. Department of Pathology, Portuguese Oncology Institute of Porto, Porto, Portugal

    Rui Henrique

  9. Department of Pathology and Molecular Immunology, Institute of Biomedical Sciences Abel Salazar-University of Porto (ICBAS-UP), Rua de Jorge Viterbo Ferreira n. 228, 4050-313, Porto, Portugal

    Rui Henrique & Carmen Jerónimo

Authors
  1. Gonçalo Outeiro-Pinho
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Daniela Barros-Silva
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Elena Aznar
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ana-Isabel Sousa
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Márcia Vieira-Coimbra
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jorge Oliveira
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Céline S. Gonçalves
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Bruno M. Costa
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Kerstin Junker
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Rui Henrique
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Carmen Jerónimo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Carmen Jerónimo.

Supplementary Information

Additional file 1: Supplementary Figure S1.

Expression of miR-30a-5p according to clinicopathological variables in Cohort #1. Scatter plots of miR-30a-5p expression levels according to metastasis presentation, recurrence and Führman grade (Mann–Whitney U test).

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Outeiro-Pinho, G., Barros-Silva, D., Aznar, E. et al. Correction: MicroRNA-30a-5pme: a novel diagnostic and prognostic biomarker for clear cell renal cell carcinoma in tissue and urine samples. J Exp Clin Cancer Res 41, 247 (2022). https://doi.org/10.1186/s13046-022-02450-x

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s13046-022-02450-x

Journal of Experimental & Clinical Cancer Research

ISSN: 1756-9966

Contact us